Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Explaining the race difference in prostate cancer stage at diagnosis.

Jones BA, Liu WL, Araujo AB, Kasl SV, Silvera SN, Soler-Vilá H, Curnen MG, Dubrow R.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2825-34. doi: 10.1158/1055-9965.EPI-08-0203. Epub 2008 Sep 30.

2.

Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status.

Vijayakumar S, Weichselbaum R, Vaida F, Dale W, Hellman S.

Cancer J Sci Am. 1996 Jul-Aug;2(4):225-33.

PMID:
9166537
3.

The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.

Pan CC, Lee JS, Chan JL, Sandler HM, Underwood W, McLaughlin PW.

Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1292-6.

PMID:
14630264
4.

Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.

Hoffman RM, Gilliland FD, Eley JW, Harlan LC, Stephenson RA, Stanford JL, Albertson PC, Hamilton AS, Hunt WC, Potosky AL.

J Natl Cancer Inst. 2001 Mar 7;93(5):388-95.

PMID:
11238701
6.

Black-white differences in survival from late-stage prostate cancer.

Polednak AP.

Ethn Dis. 2003 Spring;13(2):220-5.

PMID:
12785419
7.

Stage at diagnosis of prostate cancer in Connecticut by poverty and race.

Polednak AP.

Ethn Dis. 1997 Autumn;7(3):215-20.

PMID:
9467704
8.

Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.

Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A.

Med Care. 2004 Mar;42(3):239-50.

PMID:
15076823
9.

Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995-2004.

Robbins AS, Koppie TM, Gomez SL, Parikh-Patel A, Mills PK.

Cancer. 2007 Sep 15;110(6):1255-63.

10.

Effects of health insurance and race on early detection of cancer.

Roetzheim RG, Pal N, Tennant C, Voti L, Ayanian JZ, Schwabe A, Krischer JP.

J Natl Cancer Inst. 1999 Aug 18;91(16):1409-15.

PMID:
10451447
11.

Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis.

Zeliadt SB, Penson DF, Albertsen PC, Concato J, Etzioni RD.

Cancer. 2003 Aug 1;98(3):496-503.

12.

Prostate cancer incidence and mortality rates among white and black men.

Merrill RM, Brawley OW.

Epidemiology. 1997 Mar;8(2):126-31.

PMID:
9229202
13.

Disparities associated with advanced prostate cancer stage at diagnosis.

Marlow NM, Halpern MT, Pavluck AL, Ward EM, Chen AY.

J Health Care Poor Underserved. 2010 Feb;21(1):112-31. doi: 10.1353/hpu.0.0253.

PMID:
20173259
14.
15.

Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004.

Robbins AS, Yin D, Parikh-Patel A.

Am J Epidemiol. 2007 Jul 1;166(1):71-8. Epub 2007 Apr 9.

PMID:
17426038
16.

Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer.

Wolf MS, Knight SJ, Lyons EA, Durazo-Arvizu R, Pickard SA, Arseven A, Arozullah A, Colella K, Ray P, Bennett CL.

Urology. 2006 Jul;68(1):89-93.

PMID:
16844451
17.

Current age and race adjusted prostate specific antigen threshold values delay diagnosis of high grade prostate cancer.

Reed A, Ankerst DP, Pollock BH, Thompson IM, Parekh DJ.

J Urol. 2007 Nov;178(5):1929-32; discussion 1932. Epub 2007 Sep 17.

PMID:
17868724
18.

The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985).

Roach M 3rd, Krall J, Keller JW, Perez CA, Sause WT, Doggett RL, Rotman M, Russ H, Pilepich MV, Asbell SO, et al.

Int J Radiat Oncol Biol Phys. 1992;24(3):441-9.

PMID:
1399729
19.

Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina.

Conlisk EA, Lengerich EJ, Demark-Wahnefried W, Schildkraut JM, Aldrich TE.

Urology. 1999 Jun;53(6):1194-9.

PMID:
10367851
20.

The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment.

Mettlin CJ, Murphy GP, Cunningham MP, Menck HR.

Cancer. 1997 Oct 1;80(7):1261-6.

PMID:
9317177

Supplemental Content

Support Center